Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Arrowhead Pharmaceuticals Receives FDA Approval Of Redemplo To Reduce Triglycerides In Adults With Familial Chylomicronemia Syndrome

Author: Benzinga Newsdesk | November 18, 2025 11:13am

https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2025

Posted In: ARWR

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist